SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Menting JEA, Honig A & Verhey FRJ et al. Selective serotonin reuptake inhibitors (SSRI) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int. Clin. Psychopharmacol. 1996; 11: 165175.
  • 2
    Masand PS & Gupta S. Selective serotonin-reuptake inhibitors: An update. Harvard Rev. Psychiatry 1999; 7: 6984.
  • 3
    Haddad P. New antidepressants and the discontinuation syndrome. J. Clin. Psychiatry 1997; 58 (Suppl. 7): 1722.
  • 4
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA, Washington, DC, 1994.
  • 5
    Ishigooka J, Wakatabe H & Shimada E et al. Phase I trial on the serotonin reuptake inhibitor SME3110 (fluvoxamine maleate). Clin. Eval. 1993; 21: 441490.
  • 6
    Lejoyeux M & Ades J. Antidepressant discontinuation: a review of the literature. J. Clin. Psychiatry 1997; 58 (Suppl. 7): 1116.
  • 7
    Black DW, Wesner R & Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J. Clin. Psychiatry 1993; 54: 146149.
  • 8
    Mallya G, White K & Gunderson C. Is there a serotoninergic withdrawal syndrome? Biol. Psychiatry 1993; 33: 851852.
  • 9
    Basco MR & Rush J. Compliance with pharmacotherapy in mood disorders. Psychiatric Ann. 1995; 25: 269279.